Charlotte E. Ariyan

Active 2001–2025

52
Papers
19,079
Citations
38
h-index
48
i10-index

Citations

Citations per year for Charlotte E. Ariyan1976: 1 citations1977: 1 citations1994: 2 citations1999: 1 citations2001: 2 citations2002: 8 citations2003: 32 citations2004: 83 citations2005: 82 citations2006: 84 citations2007: 66 citations2008: 66 citations2009: 66 citations2010: 61 citations2011: 52 citations2012: 58 citations2013: 105 citations2014: 219 citations2015: 267 citations2016: 245 citations2017: 215 citations2018: 222 citations2019: 713 citations2020: 1,000 citations2021: 983 citations2022: 877 citations2023: 682 citations2024: 892 citations2025: 410 citations2026: 14 citations1978–1993: no citations, so these years are not shown1995–1998: no citations, so these years are not shown2000: no citations, so this year is not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 3,320 citing papers, 29.4% of this breakdownChina: 1,673 citing papers, 14.8% of this breakdownUnited Kingdom: 552 citing papers, 4.9% of this breakdownGermany: 534 citing papers, 4.7% of this breakdownItaly: 505 citing papers, 4.5% of this breakdownFrance: 469 citing papers, 4.1% of this breakdownAustralia: 406 citing papers, 3.6% of this breakdownCanada: 377 citing papers, 3.3% of this breakdownNetherlands: 342 citing papers, 3% of this breakdownJapan: 330 citing papers, 2.9% of this breakdownSpain: 279 citing papers, 2.5% of this breakdownSwitzerland: 241 citing papers, 2.1% of this breakdown
0%29.4%Other 20.2%

Fields

  • Medicine64.9%
  • Biochemistry, Genetics and Molecular Biology19.4%
  • Immunology and Microbiology11.2%
  • Neuroscience2.1%
  • Engineering0.8%
  • Agricultural and Biological Sciences0.4%
  • Other1.2%

Topics

  • Cancer Immunotherapy and Biomarkers14.7%
  • Immunotherapy and Immune Responses7.2%
  • CAR-T cell therapy research5.1%
  • Immune Cell Function and Interaction3.8%
  • Cutaneous Melanoma Detection and Management2.8%
  • Adipose Tissue and Metabolism2.7%
  • Other63.7%

Coauthors

All papers

Open in search
  1. Tumor mutational load predicts survival after immunotherapy across multiple cancer types

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Philip H. Gutin, Cameron Brennan, Viviane Tabar, Ingo K. Mellinghoff, Lisa M. DeAngelis, Charlotte E. Ariyan, Nancy Y. Lee, William D. Tap, Mrinal M. Gounder, Sandra P. D’Angelo, Leonard B. Saltz, Zsofia K. Stadler, Howard I. Scher, José Baselga, Pedram Razavi, Christopher A. Klebanoff, Rona Yaeger, Neil H. Segal, Geoffrey Y. Ku, Ronald P. DeMatteo, Marc Ladanyi, Naiyer A. Rizvi, Michael F. Berger, Nadeem Riaz, David B. Solit, Timothy A. Chan, Luc G.T. Morris - Nature Genetics 2019 cited by 4,358

  2. Nivolumab plus Ipilimumab in Advanced Melanoma

    Authors: , , , , , , , , , , , , , , , , , , , , , , , - New England Journal of Medicine 2013 cited by 4,221

  3. Neoadjuvant relatlimab and nivolumab in resectable melanoma

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Sapna P. Patel, Adi Diab, Anthony Lucci, Víctor G. Prieto, Michael A. Davies, James P. Allison, Padmanee Sharma, Jennifer A. Wargo, Charlotte E. Ariyan, Hussein A. Tawbi - Nature 2022 cited by 332

  4. Transcriptional Basis of Mouse and Human Dendritic Cell Heterogeneity

    Authors: , , , , , , , , , , , - Cell 2019 cited by 631

  5. Gut microbiota signatures are associated with toxicity to combined CTLA-4 and PD-1 blockade

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Khalida Wani, Alexander J. Lazar, Michael T. Tetzlaff, Courtney W. Hudgens, Margaret K. Callahan, Matthew Adamow, Michael A. Postow, Charlotte E. Ariyan, Pierre-Olivier Gaudreau, Luigi Nezi, Didier Raoult, Catalin Mihalcioiu, Arielle Elkrief, Rossanna C. Pezo, Lauren E. Haydu, Julie M. Simon, Hussein A. Tawbi, Jennifer L. McQuade, Patrick Hwu, Wen-Jen Hwu, Rodabe N. Amaria, Elizabeth M. Burton, Scott E. Woodman, Stephanie S. Watowich, Adi Diab, Sapna P. Patel, Isabella C. Glitza, Michael K.K. Wong, Li Zhao, Jianhua Zhang, Nadim J. Ajami, Joseph F. Petrosino, Robert R. Jenq, Michael A. Davies, Jeffrey E. Gershenwald, P. Andrew Futreal, Padmanee Sharma, James P. Allison, Bertrand Routy, Laurence Zitvogel, Jennifer A. Wargo - Nature Medicine 2021 cited by 415

  6. Pretreatment neutrophil-to-lymphocyte ratio and mutational burden as biomarkers of tumor response to immune checkpoint inhibitors

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , - Nature Communications 2021 cited by 456

  7. Adipocyte-Derived Lipids Mediate Melanoma Progression via FATP Proteins

    Authors: , , , , , , , , , , , , , , , , , , , , , - Cancer Discovery 2018 cited by 357

  8. Mitochondrial Dysfunction in the Elderly: Possible Role in Insulin Resistance

    Authors: , , , , , , , , - Science 2003 cited by 2,116

  9. Completion Dissection or Observation for Sentinel-Node Metastasis in Melanoma

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Tara L. Huston, Jeffrey D. Wayne, B. Mark Smithers, Heather B. Neuman, Schlomo Schneebaum, Jeffrey E. Gershenwald, Charlotte E. Ariyan, Darius C. Desai, Lisa K. Jacobs, Kelly M. McMasters, Anja Gesierich, Peter Hersey, Steven D. Bines, John M. Kane, Richard J. Barth, Gregory McKinnon, Jeffrey M. Farma, Erwin Schultz, Sergi Vidal‐Sicart, Richard Hoefer, James M. Lewis, Randall P. Scheri, Mark C. Kelley, Omgo E. Nieweg, R. Dirk Noyes, Dave S.�B. Hoon, He-Jing Wang, David Elashoff, Robert M. Elashoff - New England Journal of Medicine 2017 cited by 1,385

  10. Regulatory T Cells Restrain Interleukin-2- and Blimp-1-Dependent Acquisition of Cytotoxic Function by CD4+ T Cells

    Authors: , , , , , , , , , , , , , , , , , , , , , - Immunity 2020 cited by 227

  11. Objective Response Rate Among Patients With Locally Advanced or Metastatic Sarcoma Treated With Talimogene Laherparepvec in Combination With Pembrolizumab

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , - JAMA Oncology 2020 cited by 205

  12. Neoadjuvant systemic therapy in melanoma: recommendations of the International Neoadjuvant Melanoma Consortium

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Alexander M.M. Eggermont, Michael A. Davies, Miles C. Andrews, Donald A. Berry, Matthew S. Block, Genevieve M. Boland, Kathryn Bollin, Matteo S. Carlino, Richard D. Carvajal, Jonathan Cohen, Diwakar Davar, Keith A. Delman, Reinhard Dummer, Michael D. Farwell, David E. Fisher, Alberto Fusi, Isabella C. Glitza, Tanja D. de Gruijl, David Gyorki, Axel Hauschild, Tina J. Hieken, James Larkin, David H. Lawson, Célèste Lebbé, Jeffrey E. Lee, Michael Lowe, Jason J. Luke, Grant A. McArthur, David F. McDermott, Jennifer L. McQuade, Tara C. Mitchell, Teresa M. Petrella, Peter A. Prieto, Igor Puzanov, Caroline Robert, April K.S. Salama, Shaneen Sandhu, Dirk Schadendorf, Alexander N. Shoushtari, Jeffrey A. Sosman, Susan M. Swetter, Ken K Tanabe, Samra Turajlic, Douglas S. Tyler, Scott E. Woodman, Frances C. Wright, Jonathan S. Zager, Paolo A. Ascierto, Andrew J. Spillane, Alexander C. J. van Akkooi, Jennifer A. Wargo, Christian U. Blank, Hussein A. Tawbi, Georgina V. Long - The Lancet Oncology 2019 cited by 218

  13. High neutrophil‐to‐lymphocyte ratio (NLR) is associated with treatment failure and death in patients who have melanoma treated with PD‐1 inhibitor monotherapy

    Authors: , , , , , , , - Cancer 2019 cited by 142

  14. Anatomic position determines oncogenic specificity in melanoma

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Cecilia Lezcano, Richard P. Koche, Lorenz Studer, Charlotte E. Ariyan, David B. Solit, Jedd D. Wolchok, Taha Merghoub, Neal Rosen, Nicholas K. Hayward, Richard M. White - Nature 2022 cited by 98

  15. Imatinib potentiates antitumor T cell responses in gastrointestinal stromal tumor through the inhibition of Ido

    Authors: , , , , , , , , , , , , , , , , , - Nature Medicine 2011 cited by 521

  16. Most large structural variants in cancer genomes can be detected without long reads

    Authors: , , , , , , , , , , , , , , , , , , , - Nature Genetics 2023 cited by 41

  17. Alternative transcription initiation leads to expression of a novel ALK isoform in cancer

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Yu Chen, Ping Chi - Nature 2015 cited by 251

  18. PD-1 Blockade in Advanced Adrenocortical Carcinoma

    Authors: , , , , , , , , , , , , , , , , - Journal of Clinical Oncology 2019 cited by 186

  19. Sentinel Lymph Node Biopsy and Management of Regional Lymph Nodes in Melanoma: American Society of Clinical Oncology and Society of Surgical Oncology Clinical Practice Guideline Update

    Authors: , , , , , , , , , , , , , , - Annals of Surgical Oncology 2017 cited by 278

  20. Integrated genomic analyses reveal frequent TERT aberrations in acral melanoma

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , - Genome Research 2017 cited by 143

  21. Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immunotherapy for the treatment of melanoma, version 3.0

    Authors: , , , , , , , , , , , , , , , , , , , , , , - Journal for ImmunoTherapy of Cancer 2023 cited by 55

  22. Prognosis of Acral Melanoma: A Series of 281 Patients

    Authors: , , , , , , - Annals of Surgical Oncology 2013 cited by 153

  23. Robust Antitumor Responses Result from Local Chemotherapy and CTLA-4 Blockade

    Authors: , , , , , , , , , , , , , , , , , , , , , - Cancer Immunology Research 2018 cited by 121

  24. Paradoxical Activation of T Cells via Augmented ERK Signaling Mediated by a RAF Inhibitor

    Authors: , , , , , , , , , , , , , , , - Cancer Immunology Research 2013 cited by 120